| Product Code: ETC7477172 | Publication Date: Sep 2024 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Hong Kong continued to rely on imports of drug-eluting stents, with top exporting countries being Puerto Rico, Switzerland, USA, Netherlands, and Belgium. The market showed a high level of concentration, with the Herfindahl-Hirschman Index (HHI) remaining high in 2024. However, there was a significant decrease in growth rate from 2023 to 2024. Despite this, the compound annual growth rate (CAGR) from 2020 to 2024 was strong at 27.69%, indicating a promising trajectory for the market in the coming years.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Hong Kong Drug-eluting Stents Market Overview |
3.1 Hong Kong Country Macro Economic Indicators |
3.2 Hong Kong Drug-eluting Stents Market Revenues & Volume, 2022 & 2032F |
3.3 Hong Kong Drug-eluting Stents Market - Industry Life Cycle |
3.4 Hong Kong Drug-eluting Stents Market - Porter's Five Forces |
3.5 Hong Kong Drug-eluting Stents Market Revenues & Volume Share, By Product, 2022 & 2032F |
3.6 Hong Kong Drug-eluting Stents Market Revenues & Volume Share, By Drug, 2022 & 2032F |
3.7 Hong Kong Drug-eluting Stents Market Revenues & Volume Share, By Generation, 2022 & 2032F |
3.8 Hong Kong Drug-eluting Stents Market Revenues & Volume Share, By Scaffold, 2022 & 2032F |
3.9 Hong Kong Drug-eluting Stents Market Revenues & Volume Share, By Application, 2022 & 2032F |
3.10 Hong Kong Drug-eluting Stents Market Revenues & Volume Share, By End User, 2022 & 2032F |
4 Hong Kong Drug-eluting Stents Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cardiovascular diseases in Hong Kong |
4.2.2 Technological advancements in drug-eluting stents leading to improved patient outcomes |
4.2.3 Growing adoption of minimally invasive procedures in the healthcare sector |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for product approval and market entry |
4.3.2 High cost associated with drug-eluting stents impacting affordability for patients |
4.3.3 Competition from alternative treatments such as bare-metal stents or surgical interventions |
5 Hong Kong Drug-eluting Stents Market Trends |
6 Hong Kong Drug-eluting Stents Market, By Types |
6.1 Hong Kong Drug-eluting Stents Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Hong Kong Drug-eluting Stents Market Revenues & Volume, By Product, 2022 - 2032F |
6.1.3 Hong Kong Drug-eluting Stents Market Revenues & Volume, By Polymer-based, 2022 - 2032F |
6.1.4 Hong Kong Drug-eluting Stents Market Revenues & Volume, By Polymer-free, 2022 - 2032F |
6.2 Hong Kong Drug-eluting Stents Market, By Drug |
6.2.1 Overview and Analysis |
6.2.2 Hong Kong Drug-eluting Stents Market Revenues & Volume, By Sirolimus, 2022 - 2032F |
6.2.3 Hong Kong Drug-eluting Stents Market Revenues & Volume, By Paclitaxel, 2022 - 2032F |
6.2.4 Hong Kong Drug-eluting Stents Market Revenues & Volume, By Zotarolimus, 2022 - 2032F |
6.2.5 Hong Kong Drug-eluting Stents Market Revenues & Volume, By Everolimus, 2022 - 2032F |
6.2.6 Hong Kong Drug-eluting Stents Market Revenues & Volume, By Biolimus, 2022 - 2032F |
6.2.7 Hong Kong Drug-eluting Stents Market Revenues & Volume, By Others, 2022 - 2032F |
6.3 Hong Kong Drug-eluting Stents Market, By Generation |
6.3.1 Overview and Analysis |
6.3.2 Hong Kong Drug-eluting Stents Market Revenues & Volume, By 1st Generation, 2022 - 2032F |
6.3.3 Hong Kong Drug-eluting Stents Market Revenues & Volume, By 2nd Generation, 2022 - 2032F |
6.3.4 Hong Kong Drug-eluting Stents Market Revenues & Volume, By 3rd Generation, 2022 - 2032F |
6.3.5 Hong Kong Drug-eluting Stents Market Revenues & Volume, By 4th Generation, 2022 - 2032F |
6.4 Hong Kong Drug-eluting Stents Market, By Scaffold |
6.4.1 Overview and Analysis |
6.4.2 Hong Kong Drug-eluting Stents Market Revenues & Volume, By Cobalt-Chromium, 2022 - 2032F |
6.4.3 Hong Kong Drug-eluting Stents Market Revenues & Volume, By Platinum-Chromium, 2022 - 2032F |
6.4.4 Hong Kong Drug-eluting Stents Market Revenues & Volume, By Nitinol, 2022 - 2032F |
6.4.5 Hong Kong Drug-eluting Stents Market Revenues & Volume, By Biodegradable, 2022 - 2032F |
6.4.6 Hong Kong Drug-eluting Stents Market Revenues & Volume, By Others, 2022 - 2032F |
6.5 Hong Kong Drug-eluting Stents Market, By Application |
6.5.1 Overview and Analysis |
6.5.2 Hong Kong Drug-eluting Stents Market Revenues & Volume, By Coronary Diseases, 2022 - 2032F |
6.5.3 Hong Kong Drug-eluting Stents Market Revenues & Volume, By Peripheral Vascular Diseases, 2022 - 2032F |
6.6 Hong Kong Drug-eluting Stents Market, By End User |
6.6.1 Overview and Analysis |
6.6.2 Hong Kong Drug-eluting Stents Market Revenues & Volume, By Hospitals, 2022 - 2032F |
6.6.3 Hong Kong Drug-eluting Stents Market Revenues & Volume, By Ambulatory Surgical Centers, 2022 - 2032F |
7 Hong Kong Drug-eluting Stents Market Import-Export Trade Statistics |
7.1 Hong Kong Drug-eluting Stents Market Export to Major Countries |
7.2 Hong Kong Drug-eluting Stents Market Imports from Major Countries |
8 Hong Kong Drug-eluting Stents Market Key Performance Indicators |
8.1 Average procedure time for implanting drug-eluting stents |
8.2 Rate of complications post drug-eluting stent implantation |
8.3 Number of healthcare facilities offering drug-eluting stent procedures |
8.4 Adoption rate of new drug-eluting stent technologies |
8.5 Patient satisfaction scores related to drug-eluting stent procedures |
9 Hong Kong Drug-eluting Stents Market - Opportunity Assessment |
9.1 Hong Kong Drug-eluting Stents Market Opportunity Assessment, By Product, 2022 & 2032F |
9.2 Hong Kong Drug-eluting Stents Market Opportunity Assessment, By Drug, 2022 & 2032F |
9.3 Hong Kong Drug-eluting Stents Market Opportunity Assessment, By Generation, 2022 & 2032F |
9.4 Hong Kong Drug-eluting Stents Market Opportunity Assessment, By Scaffold, 2022 & 2032F |
9.5 Hong Kong Drug-eluting Stents Market Opportunity Assessment, By Application, 2022 & 2032F |
9.6 Hong Kong Drug-eluting Stents Market Opportunity Assessment, By End User, 2022 & 2032F |
10 Hong Kong Drug-eluting Stents Market - Competitive Landscape |
10.1 Hong Kong Drug-eluting Stents Market Revenue Share, By Companies, 2025 |
10.2 Hong Kong Drug-eluting Stents Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here